U.S. federal trademark · Serial No. 98383240
Adeno-associated virus (AAV) vectors, protein sequences and nucleic acid sequences for medical purposes; Gene therapy products, namely, biopharmaceutical preparations primarily comprised of adeno-associated virus (AAV) vectors comprising a transgene or other nucleic acid payload for delivery to a cell or tissue for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; Biological preparations as therapeutic products for medical use in medical and clinical gene therapy, namely, biological preparations for the treatment of genetic diseases, conditions and disorders of tissue, organs, muscles, and central nervous system; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells
Adeno-associated virus (AAV) vectors, protein sequences and nucleic acid sequences for use in scientfic research and pharmaceutical research; none of the foregoing in the field of analysis and treatment of tumor associated antigens utilizing immune cells
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.